ATE185698T1 - Therapeutisches agens - Google Patents

Therapeutisches agens

Info

Publication number
ATE185698T1
ATE185698T1 AT94918690T AT94918690T ATE185698T1 AT E185698 T1 ATE185698 T1 AT E185698T1 AT 94918690 T AT94918690 T AT 94918690T AT 94918690 T AT94918690 T AT 94918690T AT E185698 T1 ATE185698 T1 AT E185698T1
Authority
AT
Austria
Prior art keywords
inflammatory
xii
mixtures
compound
plant extracts
Prior art date
Application number
AT94918690T
Other languages
English (en)
Inventor
Brian Daunter
Original Assignee
Main Camp Marketing Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Main Camp Marketing Pty Ltd filed Critical Main Camp Marketing Pty Ltd
Application granted granted Critical
Publication of ATE185698T1 publication Critical patent/ATE185698T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Indole Compounds (AREA)
AT94918690T 1993-06-25 1994-06-24 Therapeutisches agens ATE185698T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPL960593 1993-06-25

Publications (1)

Publication Number Publication Date
ATE185698T1 true ATE185698T1 (de) 1999-11-15

Family

ID=3777003

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918690T ATE185698T1 (de) 1993-06-25 1994-06-24 Therapeutisches agens

Country Status (12)

Country Link
EP (1) EP0708651B1 (de)
JP (1) JPH09505024A (de)
CN (1) CN1129908A (de)
AT (1) ATE185698T1 (de)
CA (1) CA2165794A1 (de)
DE (1) DE69421280T2 (de)
ES (1) ES2140541T3 (de)
IN (1) IN178310B (de)
NZ (1) NZ267567A (de)
PL (1) PL176595B1 (de)
WO (1) WO1995000157A1 (de)
ZA (1) ZA944568B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821670D0 (en) * 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
AUPP797598A0 (en) * 1998-12-30 1999-01-28 Butters, Desley Therapeutic agent
US6352728B1 (en) * 1999-11-02 2002-03-05 International Celery Development Alliance Pty. Ltd. Extracts of celery seed for the prevention and treatment of pain, inflammation and gastrointestinal irritation
GB0211943D0 (en) * 2002-05-23 2002-07-03 Univ Sheffield Anti-helicobacter activity of celery seed components
JP4804353B2 (ja) * 2003-05-14 2011-11-02 ディーエスエム アイピー アセッツ ビー.ブイ. 糖尿病の治療及び予防のためのフタリド誘導体の使用
EP1662906A1 (de) 2003-09-23 2006-06-07 DSM IP Assets B.V. Zusammensetzungen für die behandlung und vorbeugung von diabetes mellitus
CN1257711C (zh) 2003-12-05 2006-05-31 石药集团中奇制药技术(石家庄)有限公司 丁苯酞软胶囊及其制备工艺
ES2375302T3 (es) * 2005-05-24 2012-02-28 Dsm Ip Assets B.V. Derivados de ligustilida para el tratamiento de trastornos inflamatorios.
KR20090078777A (ko) * 2006-08-11 2009-07-20 디에스엠 아이피 어셋츠 비.브이. 중추 신경계 질환의 치료를 위한 리구스틸라이드 유도체
CN100569241C (zh) * 2007-01-17 2009-12-16 北京天川军威医药技术开发有限公司 芹菜籽乙酸乙酯萃取物及其用途
US8722338B2 (en) 2009-03-11 2014-05-13 The Johns Hopkins University Modulation of ABCG2-mediated urate transport to treat hyperuricemia and gout
AU2010329604B2 (en) * 2009-11-23 2016-05-19 Bagi Research Limited Novel therapeutic methods for treating inflammation and immune system disorders
JP5581120B2 (ja) * 2010-06-07 2014-08-27 花王株式会社 電位依存性カチオンチャネル抑制剤
CN102697772A (zh) * 2012-05-08 2012-10-03 中国人民解放军第二军医大学 一种治疗痛风的药物组合物及其应用
CN103183654B (zh) * 2013-01-30 2014-11-05 泰山医学院 芹菜籽活性单体的分离纯化制备工艺
CN105535116A (zh) * 2015-12-23 2016-05-04 辽宁科技学院 一种天然药物提取物及其制备方法
CN110582480B (zh) 2017-04-21 2023-11-10 塔斯马尼亚大学 治疗化合物和方法
KR20210133463A (ko) * 2020-04-29 2021-11-08 한국 한의학 연구원 시라 추출물을 유효성분으로 함유하는 골질환의 예방, 개선 또는 치료용 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334368A1 (fr) * 1975-12-10 1977-07-08 Unilever Nv Procede d'isolation, a partir des pepins de raisin, d'une substance a activite anti-inflammatoire, et composition pour la peau, contenant une telle substance
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
DE3347658A1 (de) * 1983-12-31 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln 1.4-naphthochinonderivate mit entzuendungshemmender wirkung
JPS61257155A (ja) * 1985-05-10 1986-11-14 Horiuchi:Kk 抗酸化食品
JPS63501288A (ja) * 1985-09-20 1988-05-19 ジ・アップジョン・カンパニ− 1,4−ナフタレンジオ−ルおよび1,4−ヒドロキノン誘導体
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
FR2611502B1 (fr) * 1987-02-24 1990-03-09 Natura Medica Laboratoires Extrait de racines d'ombellifere obtenu par extraction hydroalcoolique, procede de preparation d'un tel extrait; et composition therapeutique, notamment a activite diuretique, cardiovasculaire, antalgique ou anti-inflammatoire comprenant un tel extrait
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
IT1242020B (it) * 1990-11-20 1994-02-02 Sigma Tau Ind Farmaceuti Ftalidilidene derivati della carnitina e di alcanoil carnitine e composizioni farmaceutiche che li contengono.
AU653024B2 (en) * 1991-05-30 1994-09-15 Novartis Ag Substituted diaminophthalimides and analogues

Also Published As

Publication number Publication date
ZA944568B (en) 1995-03-20
JPH09505024A (ja) 1997-05-20
DE69421280T2 (de) 2000-07-13
IN178310B (de) 1997-03-22
PL312714A1 (en) 1996-05-13
PL176595B1 (pl) 1999-06-30
EP0708651A1 (de) 1996-05-01
NZ267567A (en) 1997-10-24
CN1129908A (zh) 1996-08-28
DE69421280D1 (de) 1999-11-25
EP0708651A4 (de) 1998-03-04
WO1995000157A1 (en) 1995-01-05
CA2165794A1 (en) 1995-01-05
EP0708651B1 (de) 1999-10-20
ES2140541T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
DE69421280D1 (de) Therapeutisches agens
SE7705382L (sv) Forfarande for framstellning av foreningar som lindrar angiotensinforbunden hypertension
DE69534536D1 (de) Verwendung zur topischen anwendung von tocotrienol auf die haut und haare
EA199901115A1 (ru) Композиции и способы ингибирования фотостарения кожи
BR9908222A (pt) Composições para regular a aparência da pele
CA2232583A1 (en) Lipoic acid in topical compositions
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
ATE442124T1 (de) Sebum- und schweissabsorbierendes grundierungsset und entsprechendes mehrstufiges verfahren
MX9302968A (es) Composiciones de oxicodona de liberacion controlada.
EA200300703A1 (ru) Пищевая композиция, подходящая для поверхностного обжаривания, включающая лецитин подсолнечника
PT942751E (pt) Composicoes para o tratamento de neuropatias perifericas contendo antiodepressivos e/ou inibidores da monoamino-oxidase e/ou vitamina b12 e/ou precursores ou indutores de neurotransmissores
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
ATE185271T1 (de) Behandlung von durch talgdrüse verursachten erkrankungen mit inhibitoren der acyl coa cholesterin acyltransferase
AU5877486A (en) Composition for the treatment of acne
ATE283044T1 (de) Compactin zur behandlung von entzündungen
ATE258789T1 (de) 5-ht2-antagonisten in der behandlung venöser zustände
UA10208A (uk) Дерматологічний косметичний засіб
NO20003758L (no) Trekonserveringsmidler
AR014091A1 (es) Metodo para efectuar el tratamiento de afecciones de la piel
ES2088826B1 (es) Procedimiento de obtencion de las diaminas putrescina y cadaverina a partir de productos naturales tratados, su uso como aditivo en abonos, y abono correspondiente.
DK1021433T3 (da) Fremgangsmåde til fremstilling af naturlige 1,3-diolderivater og tilsvarende naturlige 1,3-dioxanderivater
JPS5714517A (en) Whitening cosmetic
ES2100274T3 (es) Nuevos 2-sacarinilmetil y 4,5,6,7-tetrahidro-2-sacarinilmetil fosfatos, fosfonatos y fosfinatos utiles como inhibidores de enzimas proteoliticos y composiciones y metodos de empleo de los mismos.
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties